Malvern, Pa., May 01, 2023 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax Bio”) BXRX, a pharmaceutical company focused on innovative products for
Sanofi completes acquisition of prophylaxis Bio, Inc. Paris, April 27th 2023. Sanofi today announced the conclusion of its acquireIon from prophylaxis Bio, Inc. (“Provention Organic”).
SAN DIEGO, March 17, 2023 (GLOBE NEWSWIRE) — Shareholder rights law firm Johnson Fistel, LLP has opened an investigation to determine whether the directors of
MALVERN, Penn., December 02, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (the “Company” or “Baudax Bio”) BXRX, a pharmaceutical company focused on acute care therapeutics,
With US stock futures trading lower this morning on Monday, some of the stocks that may draw investor focus today are as follows: Wall Street
biotechnology company, Bluebird Bio, Inc. BLUE announced late Friday that the Food and Drug Administration had approved its gene therapy for a rare neurodegenerative disease.
CAMBRIDGE, Mass., September 14, 2022 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc. THIRD, a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor
Recovery after a serious car accident often takes weeks to months, while severe injuries may require a year or longer. The first 72 hours usually
As remote work becomes a permanent fixture of American employment, a new national study from John Foy & Associates uncovers the rising dangers hiding behind
A groundbreaking new analysis from High Rise Financial highlights a severe and escalating crisis inside U.S. nursing homes, where tens of thousands of elderly residents